Sunshine Silver Mining & Refining saw its shares rise 27% during its debut on the New York Stock Exchange, signaling strong investor interest. AstraZeneca celebrated its transfer to the NYSE, noted as the largest by market capitalization in the exchange's 234-year history. Meanwhile, fintech company RedotPay introduced a new B2B product aimed at cutting global merchant fees by 70%. These developments highlight active market movements and innovation ahead of trading sessions.
AstraZeneca reported a 21% increase in core earnings per share to $2.63 for Q2 2026, surpassing analyst expectations of $2.50. Total revenue rose 6% to $15.38 billion, driven by strong sales in oncology and rare disease drugs, offsetting pressure fro...
AstraZeneca reported an 18% year-on-year increase in core earnings per share for Q2 2026, with revenue growth meeting full-year expectations. However, the company faces challenges as its top drug, Farxiga, approaches patent expiry in the U.S. and fac...
The FTSE 100 index gained 40 points to 10,777, supported by a drop in oil prices following a pause in US-Iran strikes and easing retail sector downturn. Retail sales improved in July, though online sales fell sharply, and wholesale volumes stabilized...
AstraZeneca reported second-quarter earnings that surpassed analyst expectations, with core earnings per share rising 21% to $2.63, though revenue slightly missed forecasts at $15.4 billion. Growth in oncology and rare diseases offset weaker sales fr...
